Dermatest proudly presents HypoSense®, a new testing method that redefines product safety standards in the cosmetics industry, in response to the growing demand for safe and effective “Hypoallergenic” products. Current studies often rely on Human Repeat Insult Patch Testing (HRIPT), a method that has faced criticism due to ethical concerns and inconsistent protocols. Recognising the need for a more reliable and ethically alternative, Dermatest has developed HypoSense® to enhance the credibility of “Hypoallergenic” claims.
Key features of HypoSense®
• Precision safety check
Detailed testing of ingredients according to particularly high-quality criteria to ensure product safety
• Comprehensive testing approach
HypoSense® combines 4-week Safety-in-Use studies with Patch tests, involving 30 test persons selected based on stringent inclusion criteria. This cohort includes individuals with sensitive skin, atopic dermatitis, allergies, and asthma, ensuring a thorough assessment across various skin sensitivities.
• Dual evaluation metrics
The focus is on both irritation and sensitisation potential, providing an understanding of a product’s interaction with sensitive skin. This double assessment is a key factor in determining whether a product is suitable for consumers who are likely to experience skin reactions.
• Ethical and transparent
By moving away from HRIPT, HypoSense® minimizes risks to participants, adhering to high ethical standards.
Versatility in application
HypoSense® is designed for a wide range of products, including cosmetics formulated for sensitive skin, as well as baby and children’s care items.
Dermatest’s HypoSense® not only elevates the standard of “Hypoallergenic” product testing but also fosters greater transparency and trust between manufacturers, brands and consumers. By ensuring that products are subjected to rigorous, ethically conducted testing, Dermatest empowers consumers to make informed choices, confident in the safety and suitability of the products they select for themselves and their families.